A series of novel salicylanilide ester derivatives were synthesized, characterized, and evaluated for cercaricidal potential against Schistosoma japonicum and molluscicidal potential against Oncomelania hupensis. Four derivatives exhibited remarkable cercaricidal activity superior to that of niclosamide. Among them, the most active compound, 4-chloro-2-((2-methoxy-4-nitrophenyl)carbamoyl)phenyl 4-methoxybenzoate (compound 4c), showed a marked minimum effective cercaricidal concentration as low as 0.43 M and significant molluscicidal activity, with a 50% lethal concentration (LC 50 ) of 0.206 g/m 2 . Particularly, compound 4c displayed 88-fold decreased fish toxicity on Danio rerio and 44-fold reduced cytotoxicity on human kidney HEK293 cells in comparison with the toxicity of niclosamide. The results indicated that 4c could serve as a promising drug candidate, with environmental safety properties, against Schistosoma japonicum at transmission stages. The preliminary molecular mechanism of target compounds in Schistosoma japonicum cercariae was also investigated. Salicylanilide ester derivatives exhibited an inhibitory effect on nitric oxide synthase (NOS) but no effect on lactate dehydrogenase (LDH) and acetylcholinesterase (AChE), and a strong and significant correlation between NOS inhibitory efficacy and cercaricidal activity was observed. In addition, 4c could downregulate the expression of NOS in a dose-dependent manner. These results suggested that NOS was probably one of the drug targets of salicylanilide esters.
S chistosomiasis japonica, caused by infection withSchistosoma japonicum, is recognized as a considerable economic and public health concern in Asia, including China, Indonesia, and the Philippines (1-3). According to estimates, over 58 million people are infected (4). Schistosome infection occurs through contact with water contaminated by cercariae, the free-living stage of the parasite shed from intermediate host Oncomelania snails (5). Although praziquantel is available for treatment, there is the fact that it cannot prevent individuals from reinfection. Repeated and intense exposure to cercariae could lead to an ineffective response of early-stage chronic cases in routine control programs, which would increase the risk of infections progressing to an advanced stage. A successful control program of the disease should be constructed as an integrated control scheme including cercaricidal methods, snail control programs, and chemotherapy.Niclosamide has a long track record as a successful molluscicide against Oncomelania snails (6, 7). Moreover, it is effective for cercaria control both under laboratory conditions and in field experiments (8-10). However, niclosamide has relatively poor solubility in water and is a well-known environmentally hazardous chemical. It has been proved highly toxic to 18 species of fish (11). It exhibited strong to moderate cytotoxicity on several human cell lines (12, 13). In the last 2 decades, most of the modifications of niclosamide have focused on improving its so...